L-Y-METHYLENEGLUTAMINE COMPOUNDS AND METHODS OF USE

Disclosed are substantially pure L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives, and methods of use thereof. In particular, the presently disclosed subject matter relates to L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives thereof, and method...

Full description

Saved in:
Bibliographic Details
Main Authors LE, Hoang Van, HOSSAIN, Md. Imran
Format Patent
LanguageEnglish
Published 25.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are substantially pure L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives, and methods of use thereof. In particular, the presently disclosed subject matter relates to L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives thereof, and methods of treating cancer. The method comprises administering one or more substantially pure L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives to a subject in need thereof.
Bibliography:Application Number: US202017597550